苑东生物股价跌5.02%，南方基金旗下1只基金重仓，持有43股浮亏损失121.26元

Group 1 - The core point of the news is that Yuan Dong Bio experienced a 5.02% drop in stock price, currently trading at 53.30 CNY per share, with a total market capitalization of 9.409 billion CNY [1] - The company, Chengdu Yuan Dong Bio-Pharmaceutical Co., Ltd., was established on June 1, 2009, and listed on September 2, 2020. Its main business involves the research, production, and sales of chemical raw materials and chemical drug formulations [1] - The revenue composition of the company includes 78.75% from formulation sales, 9.22% from raw material sales, 6.79% from technical services and transfers, 4.01% from CMO/CDMO, and 1.22% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Southern Fund has Yuan Dong Bio as a top ten holding. The Southern SSE STAR Market Comprehensive ETF Linked A (023731) held 43 shares in the third quarter, ranking as the tenth largest holding [2] - The estimated floating loss for the fund today is approximately 121.26 CNY [2] - The Southern SSE STAR Market Comprehensive ETF Linked A (023731) was established on April 8, 2025, with a latest scale of 97.6034 million CNY and a cumulative return of 34.95% since inception [2]